Other clinical studies Several meta-analyses and observational cohorts align partly with our finding of a non-statistically significant association between GLP-1 receptor agonist (GLP-1RA) use and development or progression of diabetic retinopathy (DR). Here, GLP1R is linked to diabetic retinopathy.